News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Farnum Rhonda
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/24/2023 |
4
| Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns:
| Sold 1,807 shares
@ $9.47, valued at
$17.1k
|
|
08/22/2023 |
4
| Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns:
| Paid exercise price by delivering 10,460 shares
@ $9.7, valued at
$101.5k
|
|
06/12/2023 |
4
| Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns:
| Sold 1,790 shares
@ $11.13, valued at
$19.9k
|
|
05/23/2023 |
4
| Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns:
| Paid exercise price by delivering 5,567 shares
@ $11.21, valued at
$62.4k
|
|
03/13/2023 |
4
| Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns:
| Sold 4,000 shares
@ $10.2, valued at
$40.8k
|
|
03/03/2023 |
4
| Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns:
| Granted 75,000 shares
@ $0 |
|
02/22/2023 |
4
| Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns:
| Paid exercise price by delivering 7,119 shares
@ $10.44, valued at
$74.3k
|
|
11/22/2022 |
4
| Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) has filed a Form 4 on Theravance Biopharma, Inc.
Txns:
| Paid exercise price by delivering 23,268 shares
@ $10.85, valued at
$252.5k
|
|
08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/10/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|